|
|
|
| |
|
|
| |
The latest ovarian cancer news from News Medical |
|
|
|
|  | | | | |  Metabolic rewiring could help CAR-T cells fight solid tumors This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells inside solid tumors. It highlights metabolic reprogramming as a promising strategy to improve CAR-T cell persistence, adaptability, and anti-tumor function. | |  | | | | |  How nanoparticles could help immunotherapy turn cold tumors hot Engineered nanoparticles can improve cancer immunotherapy by delivering drugs, antigens, and genetic payloads with greater precision while remodeling the tumor microenvironment. The review highlights how nano-immunotherapy could boost immune activation, improve checkpoint-blockade responses, and support more personalized cancer treatment, although safety, scalability, and clinical translation challenges remain. | | | | | | |  The importance of genetic screening for all cancer survivors Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are just as likely as those diagnosed today to carry a germline pathogenic variant (gPV) - a heritable genetic alteration - that increases cancer risk. | |
|
|
|  | | | A fluid that women with advanced ovarian cancer know all too well - ascites, the buildup of liquid in the belly - may be doing more than causing discomfort. | | | | |  Learn how to use biomarkers to accelerate clinical development success. | |
|
|
|
|
|
|
|
